Veerhealth Care (BOM:511523) Cyclically Adjusted PB Ratio: (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:511523 Veerhealth Care Ltd BOM:511523
69 GF Score
Price ₹49.75
GF Value ₹64.16
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Veerhealth Care Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Veerhealth Care  (BOM:511523) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Veerhealth Care Cyclically Adjusted PB Ratio Related Terms


Veerhealth Care Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Veerhealth Care's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veerhealth Care Cyclically Adjusted PB Ratio Chart

Veerhealth Care Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.80 1.65 0.98 1.58

Veerhealth Care Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 1.41 0.00 1.58 0.00

BOM:511523 vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Veerhealth Care's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veerhealth Care Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Veerhealth Care's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Veerhealth Care's Cyclically Adjusted PB Ratio falls into.


BOM:511523
69GF Score
Veerhealth Care Ltd BOM:511523
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veerhealth Care Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Veerhealth Care's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Veerhealth Care's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0/167.3573*167.3573
=0.000

Current CPI (Jun. 2026) = 167.3573.

Veerhealth Care Quarterly Data

Book Value per Share CPI Adj_Book
201609 9.346 105.961 14.761
201612 0.000 105.196 0.000
201703 9.267 105.196 14.743
201706 0.000 107.109 0.000
201709 9.695 109.021 14.883
201712 0.000 109.404 0.000
201803 9.448 109.786 14.402
201806 0.000 111.317 0.000
201809 9.709 115.142 14.112
201812 0.000 115.142 0.000
201903 9.579 118.202 13.562
201906 0.000 120.880 0.000
201909 10.150 123.175 13.791
201912 0.000 126.235 0.000
202003 9.919 124.705 13.312
202006 0.000 127.000 0.000
202009 10.257 130.118 13.193
202012 0.000 130.889 0.000
202103 10.126 131.771 12.861
202106 0.000 134.084 0.000
202109 10.149 135.847 12.503
202112 0.000 138.161 0.000
202203 10.060 138.822 12.128
202206 0.000 142.347 0.000
202209 10.224 144.661 11.828
202212 0.000 145.763 0.000
202303 10.717 146.865 12.212
202306 0.000 150.280 0.000
202309 11.096 151.492 12.258
202312 0.000 152.924 0.000
202403 10.920 153.035 11.942
202406 0.000 155.789 0.000
202409 11.131 157.882 11.799
202412 0.000 158.323 0.000
202503 11.111 157.552 11.803
202506 0.000 159.755 0.000
202509 11.357 162.289 11.712
202512 0.000 163.281 0.000
202603 11.463 164.272 11.678
202606 0.000 167.357 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Veerhealth Care (BOM:511523) Overvalued in 2026?

Based on GuruFocus' analysis, Veerhealth Care stock appears to be undervalued. The current stock price of ₹49.75 is trading 22.5% below its estimated GF Value™ of ₹64.16. GuruFocus considers Veerhealth Care to be Modestly Undervalued.

Key valuation signals for BOM:511523:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: ₹64.16 vs. price of ₹49.75 (22.5% below fair value)
  • GF Score™: 69/100 with 6 warning signs

No single metric tells the full story. See the BOM:511523 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Veerhealth Care Business Description

Address J.S.S. Marg, Near Kalbadevi Post Office, 629-A, 1st Floor, Gazdar House, Mumbai, MH, IND, 400 002
Veerhealth Care Ltd is an India-based pharmaceutical company. It is engaged in the business of trading and manufacturing and marketing research-based Ayurvedic medicines. It operates in a single segment namely Ayurved Pharma Products.
69GF Score

Get the complete analysis for BOM:511523

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹49.75
Price
₹64.16
GF Value